Related Experiment Video
Updated: May 11, 2026
Quantitative 3D In Silico Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
Microfluidic chemotaxis platform for differentiating the roles of soluble and bound amyloid-β on microglial
Hansang Cho1, Tadafumi Hashimoto, Elisabeth Wong
1BioMEMS Resource Center, Massachusetts General Hospital, Harvard Medical School, USA.
Abstract:
Progressive microglial accumulation at amyloid-β (Aβ) plaques is a well-established signature of the pathology of Alzheimer's disease, but how and why microglia accumulate in the vicinity of Aβ plaques is unknown. To understand the distinct roles of Aβ on microglial accumulation, we quantified microglial responses to week-long lasting gradients of soluble Aβ and patterns of surface-bound Aβ in microfluidic chemotaxis platforms. We found that human microglia chemotaxis in gradients of soluble Aβ42 was most effective at two distinct concentrations of 23 pg.mL(-1) and 23 ng.mL(-1) Aβ42 in monomers and oligomers. We uncovered that while the chemotaxis at higher Aβ concentrations was exclusively due to Aβ gradients, chemotaxis at lower concentrations was enhanced by Aβ-induced microglial production of MCP-1. Microglial migration was inhibited by surface-bound Aβ42 in oligomers and fibrils above 45 pg.mm(-2). Better understanding of microglial migration can provide insights into the pathophysiology of senile plaques in AD.
Insights
Microglia accumulate at amyloid-β plaques in Alzheimer's disease. This study found specific amyloid-β concentrations attract microglia, while surface-bound amyloid-β inhibits migration, offering insights into plaque formation.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Microglial accumulation at amyloid-β plaques is a hallmark of Alzheimer's disease (AD).
- The precise mechanisms driving microglial migration towards amyloid-β (Aβ) deposits remain unclear.
- Understanding microglial chemotaxis is crucial for elucidating AD pathogenesis.
Purpose of the Study:
- To investigate the role of soluble and surface-bound Aβ in microglial accumulation.
- To quantify microglial chemotactic responses to varying Aβ concentrations and patterns.
- To elucidate the molecular mechanisms underlying Aβ-mediated microglial migration.
Main Methods:
- Utilized microfluidic chemotaxis platforms to create controlled Aβ gradients and surface-bound patterns.
- Quantified human microglial migration in response to soluble Aβ42 monomers and oligomers.
- Assessed the impact of different concentrations and densities of surface-bound Aβ42 on microglial movement.
Main Results:
- Human microglia exhibited chemotaxis towards soluble Aβ42 at two distinct concentrations: 23 pg/mL and 23 ng/mL.
- Chemotaxis at higher Aβ concentrations was driven by Aβ gradients, while lower concentrations were enhanced by Aβ-induced MCP-1 production.
- Surface-bound Aβ42 inhibited microglial migration at densities above 45 pg/mm² for oligomers and fibrils.
Conclusions:
- Specific soluble Aβ concentrations differentially regulate microglial chemotaxis.
- Aβ-induced MCP-1 production plays a role in microglial recruitment at lower concentrations.
- Surface-bound Aβ can impede microglial migration, potentially influencing plaque structure and AD pathology.
